Author: admin
Featured in Nature Mental Health: Advancing ketamine research and brain pathology treatments
No Comments
| News
We are happy to share that Dr. Zanos, the Director of the Translational Neuropharmacology Lab, was recently featured in a Q&A article published by Nature Mental Health. The discussion explores our laboratory’s pioneering work on ketamine and its metabolites as novel treatments for brain pathologies, with particular emphasis on depression and substance use disorders. The […]
Researchers from the Zanos lab attend the European Researchers’ Night 2025
We are pleased to share that the Translational Neuropharmacology Lab participated in the European Researchers’ Night (ERN) 2025, held on September 26, 2025, at the Cyprus State Fair in Nicosia. This annual event, organized by the Research and Innovation Foundation, brings research and innovation closer to the public through interactive demonstrations and activities. Our team […]
Dr. Zanos has been recognized among world’s top 2% of scientists in the 2024 Stanford University database
We are pleased to announce that Dr. Zanos, Director of the Translational Neuropharmacology Lab, has been included in the Stanford University database of the world’s top 2% scientists, published by Elsevier. This prestigious recognition places Dr. Zanos among an elite group of researchers globally and reflects the significant impact of our laboratory’s research contributions to […]
Zanos Lab research featured in the Cypriot “Politis” Newspaper
Our Master’s student and registered pharmacist, Georgios Kousathanas, was recently featured in the Cypriot “Politis” newspaper discussing one of our research topics on ketamine as an antidepressant treatment. The article, titled “Ketamine as a Model Drug for Rapid Antidepressant Action”, covers a part of the work being conducted in our laboratory on ketamine’s rapid-acting therapeutic […]
Dr. Eleftheria Charalambous presents novel research findings on microbiome and brain health
We’re happy to share that our postdoctoral researcher Dr. Eleftheria Charalambous recently presented her latest findings at the World Federation of Societies of Biological Psychiatry (WFSBP) 2025 Congress. Her innovative research focuses on gut microbiome-wide association studies that identify specific viruses linked to mental health and brain aging. Dr. Charalambous’s work represents a significant advancement […]
Our lab members were selected and participated in a leadership training workshop through European COST actions
We are pleased to announce that Drs. Zanos and Apostolakis from the Translational Neuropharmacology Lab have been successfully selected and completed the “COST Academy – Leadership training workshop” for early-career investigators. This specialized training workshop was designed for young researchers to develop leadership skills for positions within COST consortia and broader research environments. Our laboratory’s […]
Infrastructure grant awarded to the Zanos Lab: TRACER Research Center
The Zanos Lab is proud to announce the award of €500,000 from the Research Promotion Foundation of Cyprus to establish the Translational Neuroscience and Behavioural Pharmacology Research Center (TRACER). This infrastructure grant will establish Cyprus’s first comprehensive neuropharmacology and systems neuroscience research facility, positioning our laboratory and the University of Cyprus at the forefront of […]
Dr. Andria Michael brings Neuroimmunology to young minds
We’re excited to share that our postdoctoral researcher Dr. Andria Michael has authored an insightful article in Neolaia, Cyprus’s youth newspaper, explaining the fascinating connection between the immune system, neuroscience and depression. In her piece titled “How Does the Immune System Connect with Depression?”, Dr. Michael breaks down complex neurobiological concepts for young readers, exploring […]
Exploring Misophonia via identifying innovative biomarkers
Our Ph.D. student, Ms. Despina Melanthiou presented her research project on identifying novel biomarkers for misophonia. Her work, that is being conducted at the University of Cyprus, explores the use of electroencephalography (EEG), heart rate variability (HRV), and other neuropsychophysiological markers, alongside biological markers from blood samples, to better understand this complex sensory processing disorder. […]
New preprint: Transcriptomic insights into (2R,6R)-hydroxynorketamine’s possible therapeutic effects for Opioid Use Disorder
We are excited to share our latest research led by Dr. Anna Onisiforou with contributions from Dr. Andria Michael and Mr. Morfeas Koumas now available as a preprint on bioRxiv, titled “Transcriptomic mapping of the ventral hippocampus reveals (2R,6R)-hydroxynorketamine as a potential therapeutic agent for opioid abstinence.” This study investigates the therapeutic potential of (2R,6R)-hydroxynorketamine (HNK), a […]